 LOS ANGELES, Aug. 30, 2021 GLOBE NEWSWIRE -- NASDAQ: ENOB Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced the appointment of internationally renowned scientists and public health leaders to a Scientific Advisory Board SAB focused on potential inhaled treatment and prevention of any current or future variants of SARS-CoV-2 the virus that causes COVID-19 and Influenza. 